Vulnerability of primary neurons derived from Tg2576 Alzheimer mice to oxygen and glucose deprivation: role of intraneuronal amyloid-β accumulation and astrocytes
- PMID: 28237964
- PMCID: PMC5451168
- DOI: 10.1242/dmm.028001
Vulnerability of primary neurons derived from Tg2576 Alzheimer mice to oxygen and glucose deprivation: role of intraneuronal amyloid-β accumulation and astrocytes
Abstract
Microvascular dysfunction is considered an integral part of Alzheimer disease (AD) pathogenesis, but the possible relationship between amyloid pathology, microvascular dysfunction and cell death is still unclear. In order to investigate the influence of intraneuronal amyloid-β (Aβ) accumulation on vulnerability to hypoxia, we isolated primary cortical neurons from Tg2576 (carrying the amyloid precursor protein APPSwe mutation) and wild-type fetal mice. We first demonstrated that neurons isolated from Tg2576 newborn mice show an increase in VEGFa mRNA expression and a decrease in the expression of the two VEGF receptors, Flt1 and Kdr, compared with wild-type cells. Moreover, APPSwe primary neurons displayed higher spontaneous and glutamate-induced cell death. We then deprived the cultures of oxygen and glucose (OGD) as an in vitro model of hypoxia. After OGD, APPSwe neurons display higher levels of cell death in terms of percentage of pyknotic/fragmented nuclei and mitochondrial depolarization, accompanied by an increase in the intraneuronal Aβ content. To explore the influence of intraneuronal Aβ peptide accumulation, we used the γ-secretase inhibitor LY450139, which showed that the reduction of the intracellular amyloid fully protects APPSwe neurons from OGD-induced degeneration. Conditioned medium from OGD-exposed APPSwe or wild-type astrocytes protected APPswe neurons but not wild-type neurons, during OGD. In conclusion, the presence of the mutated human APP gene, leading to the intracellular accumulation of APP and Aβ fragments, worsens OGD toxicity. Protection of APPSwe neurons can be obtained either using a γ-secretase inhibitor or astrocyte conditioned medium.
Keywords: Alzheimer's disease; Glutamate; Intraneuronal amyloid; Neurovascular coupling; Oxygen glucose deprivation; Primary neurons.
© 2017. Published by The Company of Biologists Ltd.
Conflict of interest statement
Competing interestsThe authors declare no competing or financial interests.
Figures




References
-
- Abramowski D., Wiederhold K.-H., Furrer U., Jaton A.-L., Neuenschwander A., Runser M.-J., Danner S., Reichwald J., Ammaturo D., Staab D. et al. (2008). Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition. J. Pharmacol. Exp. Ther. 327, 411-424. 10.1124/jpet.108.140327 - DOI - PubMed
-
- Baldassarro V. A., Calzà L., Fernandez M., Giardino L., Gliuliani A., Lorenzini L., Mangano C., Sivilia S. (2014). Alzheimer's disease: discussing the bench-to-bed” and the “Bed-to-Bench” pathway linking preclinical and clinical research. In Lost in Translation (ed. Srivastava R., Maksymowicz W. and Lopaczynski W.), pp. 409-442. World Scientific.
-
- Baldassarro V. A., Marchesini A., Facchinetti F., Villetti G., Calzà L., Giardino L. (2016). Cell death in pure-neuronal and neuron-astrocyte mixed primary culture subjected to oxygen-glucose deprivation: the contribution of poly(ADP-ribose) polymerases and caspases. Microchem. J. doi:10.1016/j.microc.2016.11.008 10.1016/j.microc.2016.11.008 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases